CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. X. THE CONCENTRATIONS OF CERTAIN ANTIBODIES IN GLOBULIN FRACTIONS DERIVED FROM HUMAN BLOOD PLASMA

^{Department of Bacteriology and Immunology, Harvard Medical School and School of Public Health, Boston}

The large number of the investigators who have carried out tests for certain antibodies rendered it impracticable to include as co-authors all the participants in the work to be described in this paper. Accordingly, grateful acknowledgment is here made for their insight and advice to Dr. Elliott Robinson of the Massachusetts Antitoxin and Vaccine Laboratory and Dr. A. R. Dochez of the Committee on Medical Research of the Office of Scientific Research and Development and to the following individuals for their share in providing certain of the data presented in this communication: Dr. W. C. Boyd, Boston University, Dr. W. L. Bradford, University of Rochester, Dr. M. D. Eaton, California Department of Public Health, Dr. G. Edsall, Massachusetts Antitoxin and Vaccine Laboratory, Dr. I. C. Hall, University of Colorado, Dr. G. K. Hirst, Rockefeller Institute, Dr. C. A. Janeway, Children's Hospital, Boston, Dr. S. D. Kramer, Michigan Department of Health, Dr. S. Mudd, University of Pennsylvania, Dr. M. F. Shaffer, Formerly of the Mass. Antitoxin and Vaccine Laboratory, Dr. J. Stokes, Jr., Children's Hospital, Philadelphia, and Dr. A. Wadsworth of the State of New York Health Department.

This work has been carried out under contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University.

This paper is Number 18 in the series “Studies on Plasma Proteins” from the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Find articles by Enders, J. in: JCI | PubMed | Google Scholar